IL-2 Superkine (Fc) [IL-2 (human):Fc (human) (Recombinant)]

IL-2 Superkine (Fc) [IL-2 (human):Fc (human) (Recombinant)]

Catalog Number:
P001417423ABE
Mfr. No.:
Abe32-190051
Price:
  • Size:
    10 µg
    Quantity:
    Add to Cart:
      • Overview
        • Specific Binds to human and mouse IL-2R. Interleukin-2 (IL-2) is a 133 amino acid glycoprotein with one intramolecular disulfide bond and variable glycosylation. It is secreted by activated T cells and induces proliferation and maturation of activated T cells, natural killer cells and lymphokine activated killer cells. IL-2 also stimulates proliferation of antibody-producing B cells, activates neutrophils and induces mononuclear cells to secrete IFN-gamma and TNF-alpha and -beta. Moreover, studies have shown that IL-2 is required for activation-induced apoptosis, an important homeostatic mechanism in the immune system, which is involved in the maintenance of peripheral tolerance to self-antigens. IL-2 promotes T cell proliferation and particularly naive T cells. IL-2 signaling on activated T cells is effected through a quaternary high-affinity receptor complex consisting of IL-2, IL-2Ralpha (CD25), IL-2Rbeta and IL-2Rgamma. Naive T cells are relatively insensitive to IL-2 as they only express small amounts of IL-2Rbeta and IL-2Rgamma. They only acquire sensitivity after CD25 expression, which captures the cytokine and presents it to the IL-2Rbeta and IL-2Rgamma receptors. IL-2 Superkine (Fc) is an artificial variant of IL-2 containing mutations at positions L80F / R81D / L85V / I 86V / I92F. These mutations are located in the molecules core that acts to stabilize the structure and to give it a receptor-binding conformation mimicking native IL-2 bound to CD25. These mutations effectively eliminate the functional requirement of IL-2 for CD25 expression and elicit proliferation of T cells. Compared to IL-2, the IL-2 superkine induces superior expansion of cytotoxic T cells, leading to improved antitumour responses in vivo, and elicits proportionally less toxicity by lowering the expansion of Tregulatory cells and reducing pulmonary oedema.

          Please contact us at for specific academic pricing.

      • Properties
        • Protein Name
          IL-2 Superkine (human):Fc (human) (rec.); Interleukin-2; T Cell Growth Factor; TCGF; Aldesleukin; Super-2
          Source
          HEK293 cells
          Type
          Recombinant Proteins
          Reactivity
          Human
          Purification
          >=95% (SDS-PAGE)
          Formulation
          Reconstitute with 100 µl sterile water.0.1mg/ml after reconstitution. Lyophilized. Contains PBS.
          Storage
          Short Term Storage +4°C ; Long Term Storage-20°C ; After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. PBS containing at least 0. 1% BSA should be used for further dilutions. Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.
          Endotoxin
          <0.01EU/μg protein (LAL test; Lonza).
          Activity
          Triggers T cell proliferation at concentration <10ng/ml in the presence of 250ng/mL each of anti-CD3 (ANC-144-020) and anti-CD28 (ANC-177-020) antibodies. Triggers far greater antitumor responses than native IL-2 in vivo but with lower toxicity.

          * For Research Use Only. Not for use in diagnostic/therapeutics procedures.

      • Applications
        • Application
          Functional Assay

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.